🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 20 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/06/2006 | 24,85 | 26,18 | 24,85 | 26,11 | +5,18% | 5,37% | 1.127.600 |
| 14/06/2006 | 24,66 | 25,18 | 24,45 | 24,82 | +0,61% | 2,98% | 512.600 |
| 13/06/2006 | 24,77 | 25,42 | 24,42 | 24,67 | -0,16% | 4,06% | 1.110.800 |
| 12/06/2006 | 25,16 | 25,45 | 24,63 | 24,71 | -1,94% | 3,26% | 620.600 |
| 09/06/2006 | 25,56 | 25,69 | 25,18 | 25,20 | -0,77% | 2,00% | 507.200 |
| 08/06/2006 | 25,38 | 25,86 | 24,86 | 25,40 | +1,58% | 3,94% | 1.798.600 |
| 07/06/2006 | 24,89 | 25,37 | 24,77 | 25,00 | +0,22% | 2,41% | 1.018.600 |
| 06/06/2006 | 24,72 | 25,01 | 24,38 | 24,95 | +0,79% | 2,55% | 859.400 |
| 05/06/2006 | 25,42 | 25,42 | 24,75 | 24,75 | -3,11% | 2,64% | 1.272.000 |
| 02/06/2006 | 25,11 | 25,68 | 25,09 | 25,55 | +2,16% | 2,33% | 1.468.400 |
| 01/06/2006 | 24,18 | 25,01 | 23,98 | 25,01 | +3,84% | 4,24% | 1.246.200 |
| 31/05/2006 | 24,92 | 24,92 | 24,07 | 24,08 | -2,88% | 3,41% | 1.391.200 |
| 30/05/2006 | 24,87 | 25,12 | 24,65 | 24,80 | -1,43% | 1,87% | 968.200 |
| 26/05/2006 | 24,36 | 25,24 | 24,35 | 25,16 | +3,39% | 3,65% | 1.158.800 |
| 25/05/2006 | 24,19 | 24,34 | 23,50 | 24,33 | +0,83% | 3,47% | 1.514.800 |
| 24/05/2006 | 23,89 | 24,44 | 23,50 | 24,13 | +0,63% | 3,91% | 1.151.600 |
| 23/05/2006 | 24,16 | 24,67 | 23,92 | 23,98 | -0,52% | 3,08% | 1.079.200 |
| 22/05/2006 | 25,00 | 25,00 | 23,61 | 24,11 | -3,68% | 5,56% | 1.925.800 |
| 19/05/2006 | 24,56 | 25,17 | 24,44 | 25,03 | +1,23% | 2,95% | 1.049.800 |
| 18/05/2006 | 25,44 | 25,74 | 24,66 | 24,72 | -1,92% | 4,25% | 1.144.000 |
| 17/05/2006 | 24,99 | 25,35 | 24,56 | 25,21 | +1,04% | 3,16% | 1.670.400 |
| 16/05/2006 | 25,77 | 25,90 | 24,94 | 24,95 | -3,22% | 3,73% | 1.393.200 |
| 15/05/2006 | 25,99 | 26,38 | 25,77 | 25,78 | -1,57% | 2,35% | 858.200 |
| 12/05/2006 | 26,45 | 26,60 | 25,63 | 26,19 | -1,37% | 3,67% | 1.572.400 |
| 11/05/2006 | 27,03 | 27,17 | 26,38 | 26,55 | -2,08% | 2,90% | 715.400 |
| 10/05/2006 | 27,34 | 27,39 | 27,03 | 27,12 | -1,20% | 1,32% | 523.000 |
| 09/05/2006 | 27,62 | 27,72 | 27,33 | 27,45 | -1,29% | 1,39% | 635.600 |
| 08/05/2006 | 28,16 | 28,16 | 27,66 | 27,81 | -0,96% | 1,79% | 442.800 |
| 05/05/2006 | 27,76 | 28,38 | 27,47 | 28,08 | +1,72% | 3,30% | 1.074.600 |
| 04/05/2006 | 27,38 | 27,95 | 27,33 | 27,60 | +0,31% | 2,28% | 1.152.400 |